Zhang Yan, Qiao Wen-Bin, Shan Li
Department of Thoracic Oncology, Tumor Hospital Affiliated to Xinjiang Medical University, Xinjiang, People's Republic of China.
Onco Targets Ther. 2018 Jun 11;11:3385-3393. doi: 10.2147/OTT.S162523. eCollection 2018.
FOXM1 is a key member of the FOX transcription factor family, which plays a vital role in a series of physiological processes. In the present study, non-small cell lung cancer (NSCLC) patients and cell lines were studied to explore the correlation between FOXM1 expression and this malignancy.
The expression status of FOXM1 was detected in 128 cases of NSCLC tissues and NSCLC cell lines. The relationship of FOXM1 expression and clinicopathological features of NSCLC patients was evaluated by us. In addition, we also explored the biological functions of FOXM1 in NSCLC cell lines.
The FOXM1 is highly expressed in NSCLC tissues and cell lines. FOXM1 expression was closely correlated with lymph node status and TNM stage. Cox regression analysis were performed to demonstrate the prognosis role of FOXM1.
FOXM1 conferred a proliferation and invasion advantage to NSCLC cell. The FOXM1 can be regarded as an important molecular marker in NSCLC prognosis.
FOXM1是FOX转录因子家族的关键成员,在一系列生理过程中发挥着至关重要的作用。在本研究中,对非小细胞肺癌(NSCLC)患者和细胞系进行研究,以探讨FOXM1表达与这种恶性肿瘤之间的相关性。
检测128例NSCLC组织和NSCLC细胞系中FOXM1的表达状态。我们评估了FOXM1表达与NSCLC患者临床病理特征的关系。此外,我们还探讨了FOXM1在NSCLC细胞系中的生物学功能。
FOXM1在NSCLC组织和细胞系中高表达。FOXM1表达与淋巴结状态和TNM分期密切相关。进行Cox回归分析以证明FOXM1的预后作用。
FOXM1赋予NSCLC细胞增殖和侵袭优势。FOXM1可被视为NSCLC预后的重要分子标志物。